Cargando…
Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury through NLRP3 Inflammasome-Mediated Pyroptosis Inhibition via Activating Nrf2
As one of the fundamental components of Astragalus membranaceus, astragaloside IV (AST IV) exerts protective effects against cerebral ischemia-reperfusion injury (CIRI). Nevertheless, the underlying mechanisms have not yet been conclusively elucidated. To do so, here, we report on the regulatory eff...
Autores principales: | Xiao, Lan, Dai, Ziwei, Tang, Wenjing, Liu, Canwen, Tang, Biao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739174/ https://www.ncbi.nlm.nih.gov/pubmed/35003524 http://dx.doi.org/10.1155/2021/9925561 |
Ejemplares similares
-
Effect of the combination of astragaloside IV and Panax notoginseng saponins on pyroptosis and necroptosis in rat models of cerebral ischemia-reperfusion
por: Tang, Biao, et al.
Publicado: (2021) -
Antihypertension effect of astragaloside IV during cerebral ischemia reperfusion in rats
por: Shen, Fengyan, et al.
Publicado: (2022) -
Protective Effects of Remimazolam on Cerebral Ischemia/Reperfusion Injury in Rats by Inhibiting of NLRP3 Inflammasome-Dependent Pyroptosis
por: Shi, Min, et al.
Publicado: (2022) -
Astragaloside IV alleviates heart failure by modulating Nrf-2
por: Feng, Wenxiao, et al.
Publicado: (2022) -
Research Progress on the Ability of Astragaloside IV to Protect the Brain Against Ischemia-Reperfusion Injury
por: Kang, Xianhui, et al.
Publicado: (2021)